雅米克治疗公司推出了0.74准确度的AI药物发现模型"Enchant", 潜在地将药物开发成本削减一半. Iambic Therapeutics launches AI drug discovery model "Enchant" with 0.74 accuracy, potentially cutting drug development costs in half.

在Nvidia的支持下,Imbic治疗学公司推出了一个AI药物发现模型“Encant ” 。 该模型以0.74的精确度预测药物在早期开发阶段的有效性,超过了以前的模型的0.58分。 Iambic Therapeutics, supported by Nvidia, has launched "Enchant," an AI drug discovery model that predicts a drug's effectiveness during early development stages with 0.74 accuracy, surpassing previous models' 0.58 score. 这一创新有可能将药物开发成本降低一半。 This innovation could potentially reduce drug development costs by half. 这一进展与制药部门对AI和其他技术的日益整合是一致的,预计到2031年制药部门将大幅扩展。 The advancement aligns with the growing integration of AI and other technologies in the pharmaceutical sector, which is projected to expand significantly by 2031.